$ Value
$0
Shares
9,847
Price
$0
Filed
Feb 12
Insider
Name
Thomas James D
Title
Chief Financial Officer
CIK
0001784360
Roles
Transaction Details
Transaction Date
2026-02-10
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
145,287
Footnotes
On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting. | On February 26, 2025, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.
Filing Info
Thomas James D's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-06 | NUS | A | $0 |
| 2026-02-26 | NUS | F | $247K |
| 2026-02-15 | NUS | F | $98K |
| 2026-02-10 | NUS | A | $0 |
| 2026-02-10 | NUS | A | $0 |
| 2025-08-01 | NUS | F | $8K |
Other Insiders at NUS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| WOODBURY EDWINA D | — | — | 2026-03-11 |
|
NAPIERSKI RYAN S
President and CEO
|
— | — | 2026-03-06 |
|
Thomas James D
Chief Financial Officer
|
— | — | 2026-03-06 |
|
Clark Chayce David
EVP and General Counsel
|
— | — | 2026-02-26 |
|
Clark Chayce David
EVP, COO and CLO
|
— | — | 2026-03-06 |
|
Hatchett Steven Keith
Chief Product Officer
|
— | — | 2026-03-06 |
|
Keisel Justin S
EVP, President of Global Sales
|
— | — | 2026-03-06 |